NMN (nicotinamide mononucleotide) is the NAD+ precursor with the most consumer-market traction and the most active research base in longevity. The mechanism is real - NAD+ declines with age, NMN raises NAD+ in published trials, and several intermediate biomarkers move in the expected direction. The question every NMN buyer should ask is: is the protocol actually moving anything in MY physiology, or am I paying $80-160/month for a placebo?
The loading protocol below is built to answer that question. The dose ramp, timing, and biomarker cadence are calibrated against the published trials. Most importantly, the protocol includes the biomarker measurement schedule that lets you decide at month 3 whether to continue, change brands, or stop. NMN without the measurement loop is faith-based supplementation.
Establish a sustainable NMN dosing protocol with the dosing schedule, ramp pattern, and biomarker cadence needed to evaluate whether the protocol is producing measurable effects for your physiology - vs paying $80-160/month for a supplement that may or may not be doing anything.
- A reputable NMN product (third-party tested for purity + dose) - we cover the credible options at /tag/nmn
- A baseline epigenetic age test (TruDiagnostic TruAge) before starting - retest at month 3 + 6 to evaluate
- A blood panel that includes NAD+ if your lab offers it (most do not - this is the key reason most users cannot evaluate their own protocol)
- Patience for a 90-day minimum trial - the published NMN trials all run 12+ weeks for measurable outcomes
How to run it
Establish baseline (week 0)
week 0 setupBefore taking the first dose: TruAge epigenetic age test, standard blood panel, document subjective measures (sleep quality, energy, recovery from workouts). This is the most-skipped step and the reason most users cannot evaluate their own NMN protocol.
Week 1-2: Start at half-dose
week 1-2Begin at 250mg/day taken first thing in the morning on an empty stomach. The empty-stomach timing matters - food cuts NMN bioavailability by an estimated 40-60%. Test for GI tolerance + headache at the half-dose before ramping.
Week 3+: Ramp to full dose
week 3+If week 1-2 was tolerated, ramp to the full clinical-trial-tier dose (typically 500-1000mg/day). Liposomal formulations often dose lower (250-500mg) because of the bioavailability advantage. Continue the empty-stomach morning timing.
Week 4: Subjective measure check
week 4At 4 weeks, log subjective measures again (sleep, energy, recovery). The published trials report meaningful subjective changes by week 4-6 - if you see absolutely nothing by week 4, this is the early signal that your physiology may not be responding.
Month 3: First biomarker re-test
month 3Re-test TruAge + standard panel at 12 weeks. The published epigenetic age changes from NMN protocols are small (typically 0.3-1.2 years over 6 months) - do not over-interpret a single 3-month reading. The key question is whether the trajectory is moving in the expected direction.
Decision point: continue, change, or stop
decision pointAt month 3, you have three options. Continue if subjective + epigenetic signals are moving in the right direction. Change brands or formulation if you see no subjective response (the bioavailability difference between brands is real). Stop if neither subjective nor biomarker signals show movement after 90 days at full dose - you have answered the question for your physiology.
What this protocol uses
Liposomal NMN with higher bioavailability claim - typically dosed at 250-500mg/day, lower than non-liposomal protocols at 1000mg. The right pick for the buyer wanting maximum bioavailability at moderate dose.
Epigenetic age testing is the only credible biomarker for evaluating a longitudinal NMN protocol. Baseline at week 0 + retest at month 3 + 6. Without this measurement loop the NMN protocol is unevaluable.
Continuous sleep + HRV tracking - the subjective measures most users notice first if NMN is producing effects in their physiology. Useful for the week-4 subjective-measure check.
Common pitfalls
- Skipping the baseline measurements. The single most common reason NMN buyers cannot evaluate their own protocol is starting without a baseline TruAge + blood panel. Three months later they have no comparison point.
- Taking it with food. NMN bioavailability drops 40-60% with food in the stomach - the empty-stomach morning timing is part of the protocol, not optional.
- Brand-hopping every 30 days. The published trials run 12+ weeks; switching brands at 30 days resets the clock and makes evaluation impossible.
- Continuing indefinitely without re-testing. NMN is $80-160/month. If subjective + biomarker signals show nothing at month 3 + 6, continuing for 2 years is the most expensive way to find out the protocol does not work for your physiology.
Advanced patterns + alternatives
NMN + NR rotation
Some practitioners rotate NMN + NR (nicotinamide riboside) on alternating quarters. The biochemistry rationale is reasonable (different uptake pathways); the published comparative-trial data is thin. Useful for buyers wanting to test both precursors.
NMN + resveratrol stack
The original Sinclair-lab pairing. Resveratrol acts as a SIRT1 activator; theory is the combination produces stronger NAD+ effects than either alone. Published evidence is mixed; useful for the buyer who has already run a pure-NMN baseline and wants to test the addition.
The NMN Loading Protocol - FAQ
How much NMN should I take?
The published clinical trials use 250mg to 1000mg/day. Liposomal formulations typically dose 250-500mg (higher bioavailability). Non-liposomal standard NMN typically doses 500-1000mg. Start at half your target dose for week 1-2 to test GI tolerance, then ramp.
When should I take NMN?
First thing in the morning on an empty stomach, 30+ minutes before food or coffee. Food cuts bioavailability 40-60%. Morning timing is preferred over evening - some users report sleep disruption from evening NAD precursor dosing.
How long until I see effects?
Subjective effects (energy, sleep quality, recovery from workouts) typically show up at week 4-6 if they are going to. Biomarker effects (epigenetic age, NAD+ levels) require 12+ weeks of consistent dosing to evaluate. If you see absolutely nothing by month 3 at full dose, the protocol may not be working for your physiology.
Are the brand differences real or marketing?
Real, mostly in two dimensions. (1) Third-party testing for purity + actual dose - some cheap NMN tests at meaningfully lower potency than label claims. (2) Bioavailability formulation - liposomal NMN produces higher blood NMN levels per mg than standard powder in published comparisons. Pay for the third-party-tested liposomal options at the credible brands.
How do I know if it is working?
Baseline TruDiagnostic TruAge + standard blood panel + subjective measures (sleep, energy, recovery) BEFORE starting. Re-test at month 3 and 6. The published NMN trials show small biomarker changes (epigenetic age shifts of 0.3-1.2 years over 6 months) - do not expect dramatic single-test changes. The trajectory matters more than the single reading.
Not medical advice. This playbook describes a protocol pattern that serious users run. It is not medical advice and not a substitute for clinician consultation. Cleared physician review is required before adopting any protocol if you have cardiovascular disease, are pregnant, or manage a chronic condition.